Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neuroblastoma × Bevacizumab × Clear all

Phase

Status

Completed 4 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 28 Carcinoma, Hepatocellular 14 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 8 Glioblastoma 6 Colonic Neoplasms 6 Breast Neoplasms 6 Lung Neoplasms 5 Liver Neoplasms 5 Rectal Neoplasms 4 Neoplasm Metastasis 4 Stomach Neoplasms 3 Sarcoma 3 Melanoma 3 Colorectal Cancer Metastatic 3 Carcinoma, Renal Cell 3 Carcinoma 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Nasopharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Endometrial Neoplasms 2

Interventions

Cyclophosphamide 11 Magnetic Resonance Spectroscopy 8 dinutuximab 6 Topotecan 6 Temozolomide 6 Irinotecan 6 Biopsy 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 sargramostim 3 Isotretinoin 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Etoposide 3 Colony-Stimulating Factors 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 naxitamab 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 fludarabine 2 erdafitinib 2 ensartinib 2 Nivolumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02308527 2024-05-14

BEACON

University of Birmingham

Phase 2 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡